MedTrace Logo

Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer

NCT04282876 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-08-08

No results posted yet for this study

Summary

Bladder cancer is often treated with cystectomy or radiation therapy. Following radiation therapy patients will often have severe side effects from the treatment. Studies have suggested that simultanously treatment with androgen deprivation therapy during radiation therapy may be able to proctect stemcells in the bladder, thus improving tissue recovering post-radiation, which would result in improved bladder compliance following the treatment and ultimately result in fewer side effects and overall improved patient quality of life.

Conditions

Interventions

DRUG

Degarelix

Patients receiving Degarelix

Sponsors & Collaborators

  • Aarhus University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-19
Primary Completion
2024-02-01
Completion
2025-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04282876 on ClinicalTrials.gov